Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > tld 1433 & Roswell

<< Previous

Bullboard Posts

Next >>

Post by patience69on Feb 03, 2021 1:57pm

243 Views

Post# 32460094

tld 1433 & Roswell

Very interesting discussion on this trial. Clearly 1433 would be better than Photofrin. Seems odd that here is nothing official announcing the trial.
I know that I have made this point before but it just seems like that would be breaking up the technology by indication. If we got a dollar for this agreement would that not knock a dollar at least off the value of our entire war chest? Lung cancer is lucrative. Just that IMHO but it seems hold out for possible xray activation & a total buy out.. Bladder & all. !!!

<< Previous

Bullboard Posts

Next >>

Rick Rule’s election insights: Gold, USD, and Canadian gas